Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
Great product, great quality
Whether you are located in Bend, Oregon, Seattle, Washington, or receiving care in California, Oregon, or Washington through telehealth, our team is available to help answer questions about your medication and treatment plan
compounding pharmacies and have not been reviewed by the FDA for safety, effectiveness, or quality
Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations
This initial discussion ensures that the treatment aligns with the patients aesthetic goals, ultimately contributing to a satisfying experience
It aids in turning fat into energy within the body
